These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15193393)

  • 1. Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526.
    Rao V; Hinz ME; Roberts BA; Fine D
    Vaccine; 2004 Jun; 22(20):2667-73. PubMed ID: 15193393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apropos "neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates".
    Arya SC; Agarwal N
    Vaccine; 2008 Aug; 26(35):4413. PubMed ID: 18602962
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
    Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
    Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
    Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD
    Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice.
    Hart MK; Lind C; Bakken R; Robertson M; Tammariello R; Ludwig GV
    Vaccine; 2001 Nov; 20(3-4):616-22. PubMed ID: 11672929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
    Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN
    Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
    Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
    PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
    Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
    Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
    Vaccine; 2010 Apr; 28(18):3143-51. PubMed ID: 20193792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development.
    Sharma A; Gupta P; Glass PJ; Parker MD; Maheshwari RK
    Vaccine; 2011 Jan; 29(5):953-9. PubMed ID: 21115048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination.
    Perkins SD; O'Brien LM; Phillpotts RJ
    Vaccine; 2006 Apr; 24(17):3440-5. PubMed ID: 16527377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.